At a glance
ClinicalIndex Comparison RecordN/ACompleted· 419 enrolled
Drug / intervention
JARDIANCE®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance in Japan on Drug Use of JARDIANCE® Tablets in Elderly Patients With Type 2 Diabetes Mellitus
In Brief
An observational study evaluating JARDIANCE® for Diabetes Mellitus, Type 2. Completed, enrolled 419 participants across 1 site.
Detailed Summary
Study to investigate the safety and efficacy of daily use of JARDIANCE® Tablets in Japanese elderly patients with type 2 diabetes mellitus.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesJapan
CollaboratorsEli Lilly and Company
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 2015
Enrollment StartFeb 2015
Primary CompletionSep 2016
TodayJul 2026
First PostedFeb 20, 2015
Enrollment StartFeb 24, 2015
Primary CompletionSep 27, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.4 years ago
Interventions
JARDIANCE®drug
JARDIANCE®